Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2023

Summary of Significant Accounting Policies [Abstract]

Schedule of Fair Values of Financial Instruments

The fair value of the Company’s financial instruments are as follows:

	Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1)		Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2)		Significant Unobservable Inputs (Level 3)
Marketable securities as of June 30, 2023	$	338	$	-	$	-
Marketable securities as of December 31, 2022	$	612	$	-	$	-

Schedule of Basic Earnings Per Share and Diluted Earnings Per Share

The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the three and six months ended June 30, 2023 and 2022.

	Three Months Ended June 30,					Six Months Ended June 30,
	2023			2022		2023			2022
Numerator:
Net (loss) income	$	(1,076,659	)	$	2,279,550	$	(2,180,190	)	$	1,105,947
Denominator:
Weighted average shares outstanding, basic		43,602,565			43,142,312		43,602,565			42,102,885
Dilutive effect of options and warrants		-			2,178,818		-			3,146,011
Weighted average shares outstanding, diluted		43,602,565			45,321,130		43,602,565			45,248,896
Net (loss) income per share, basic	$	(0.02	)	$	0.05	$	(0.05	)	$	0.03
Net (loss) income per share, diluted	$	(0.02	)	$	0.05	$	(0.05	)	$	0.02

Schedule of Computation of Diluted Net (Loss) Income Per Share

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net (loss) income per share because the effect of their inclusion would have been anti-dilutive.

	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2023		2022		2023		2022
Warrants to purchase common shares		9,362,076		2,970,826		9,362,076		2,970,826
Options to purchase common shares		4,098,000		1,883,000		4,098,000		983,000
Total potentially dilutive securities		13,460,076		4,853,826		13,460,076		3,953,826